Comprehensive cannabinoid profiling from whole blood by LC-MS/MS. Cannabis therapy monitoring for research.
This research panel provides quantitative profiling of 11 cannabinoids and metabolites from whole blood, supporting cannabis therapy monitoring and pharmacokinetic research.
Clinical indications include:
11 cannabinoids: CBD, THC, CBG, CBN, CBC, and their primary metabolites.
All 11 cannabinoids are quantified simultaneously by LC-MS/MS from whole blood, with chromatographic separation of isobaric species (CBD/THC) and stable isotope internal standardisation.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.